The LGL Group to Present at the Sidoti Micro-Cap Virtual Conference on January 18, 2024 – Chairman and Co-CEO Marc Gabelli and Co-CEO Tim Foufas to Present
ORLANDO, Fla.–(BUSINESS WIRE)–The LGL Group, Inc. (NYSE American: LGL) (“LGL, “LGL Group”, or the “Company”) is pleased to announce... Read more.
Yext to Present at Upcoming Investor Conferences
Senior executives will also be available for one-on-one and group meetings with attending investors. NEW YORK–(BUSINESS WIRE)–Yext, Inc. (NYSE: YEXT),... Read more.
Natera Provides Update on Ravgen Trial
No willful infringement, damages significantly less than what Ravgen was seeking AUSTIN, Texas–(BUSINESS WIRE)–Natera, Inc. (NASDAQ: NTRA), a global... Read more.
JPMorgan Chase Elects Mark Weinberger to its Board of Directors
NEW YORK–(BUSINESS WIRE)–JPMorgan Chase (NYSE: JPM) announced today that Mark Weinberger, 62, has been elected to its Board of Directors, effective immediately.... Read more.
Acrisure Announces Pricing of Notes Offering
GRAND RAPIDS, Mich.–(BUSINESS WIRE)–Acrisure, LLC (the “Company”) and Acrisure Finance, Inc. (together with the Company, the “Issuers”) announced... Read more.
NewMarket Corporation Completes the Acquisition of AMPAC Intermediate Holdings, LLC
RICHMOND, Va.–(BUSINESS WIRE)–NewMarket Corporation (NYSE: NEU) today announced that it has completed the acquisition of AMPAC Intermediate Holdings,... Read more.
Ares Capital Corporation Prices Public Offering of $1.00 Billion 5.875% Unsecured Notes Due 2029
NEW YORK–(BUSINESS WIRE)–Ares Capital Corporation (Nasdaq: ARCC) announced that it has priced an underwritten public offering of $1.00 billion in aggregate... Read more.
WaFd Announces Quarterly Earnings Per Share of $0.85
SEATTLE–(BUSINESS WIRE)–$wafd #earnings–WaFd, Inc. (Nasdaq: WAFD) (the “Company”), parent company of Washington Federal Bank (“WaFd... Read more.
Data from a Phase 1b Study of Quemliclustat-Based Regimens Showed Promising Overall Survival in Treatment-Naïve Metastatic Pancreatic Cancer
Median Overall Survival was 15.7 months for all patients treated with 100 mg quemliclustat-based regimens in the ARC-8 study, which exceeds the historical benchmark... Read more.
First Bancshares, Inc. Announces Securities Portfolio Repositioning and 2023 Fourth Quarter Earnings Call Information
HATTIESBURG, Miss.–(BUSINESS WIRE)–First Bancshares, Inc. (NASDAQ: FBMS) (the “Company”), holding company of The First Bank (“The First”), has... Read more.